Hap Trading, LLC Moderna, Inc. Call Options Transaction History

Hap Trading, LLC

$840 Billion
Q2 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $491,691 - $645,711	5,100 Added 45.13%	16,400 $1.69 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $1.34 Million - $1.81 Million	11,300 New	11,300 $1.37 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $4.3 Million - $7.62 Million	36,300 Added 79.08%	82,200 $622,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $566,736 - $932,064	-4,800 Reduced 9.47%	45,900 $149,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $1.46 Million - $2.21 Million	-12,500 Reduced 19.78%	50,700 $550,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $2.73 Million - $5.08 Million	-21,600 Reduced 25.47%	63,200 $1.3 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $1.24 Million - $2.03 Million	5,500 Added 6.94%	84,800 $3.35 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $8.19 Million - $17.9 Million	36,900 Added 87.03%	79,300 $8.09 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $441,694 - $798,932	3,400 Added 8.72%	42,400 $3.41 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $5.12 Million - $8.72 Million	-46,900 Reduced 54.6%	39,000 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $1.72 Million - $4.45 Million	26,200 Added 43.89%	85,900 $1.82 Million
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $7.88 Million - $13.8 Million	-145,100 Reduced 70.85%	59,700 $863,000
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $4.97 Million - $13.4 Million	167,500 Added 449.06%	204,800 $1.54 Million
Q1 2020 May 08, 2020	BUY	$17.78 - $31.58 $663,194 - $1.18 Million	37,300 New	37,300 $237,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account